Driehaus Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Driehaus Capital Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,038,257	Closed	-$94.7M	–	466
2023 Q2	$94.7M	Buy	2,038,257 +36,704	+2%	+$1.27M	1.2%	14
2023 Q1	$57.3M	Buy	2,001,553 +47,847	+2%	+$1.42M	0.8%	23
2022 Q4	$61M	Sell	1,953,706 -18,087	-0.9%	-$590K	0.91%	16
2022 Q3	$40M	Sell	1,971,793 -258,745	-12%	-$4.71M	0.61%	39
2022 Q2	$34.6M	Buy	2,230,538 +105,310	+5%	+$1.81M	0.56%	41
2022 Q1	$40.7M	Sell	2,125,228 -21,414	-1%	-$382K	0.5%	53
2021 Q4	$54.3M	Buy	2,146,642 +93,242	+5%	+$2.73M	0.55%	56
2021 Q3	$67.2M	Buy	+2,053,400	New	+$69.9M	0.8%	26

Driehaus Capital Management's DICE Position: Q3 2023 in Review

Driehaus Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 2,038,257 shares — an estimated $94.7M sold.

Driehaus Capital Management first reported a position in DICE in Q3 2021 and held it in 8 quarters. The position peaked at $94.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Driehaus Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Driehaus Capital Management sold 2,038,257 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $94.7M.
Driehaus Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Driehaus Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $94.7M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.